S9 nonclinical evaluation for anticancer pharmaceuticals: questions and answers
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Guidance for industry
- Contributor(s):
- United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Biologics Evaluation and Research (U.S.), issuing body. Center for Drug Evaluation and Research (U.S.), issuing body.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, June 2018
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Antineoplastic Agents -- therapeutic use Clinical Trials as Topic Drug Evaluation, Preclinical Antineoplastic Agents -- toxicity Drug Approval Drug Contamination Research Design Toxicity Tests Humans United States United States. Department of Health and Human Services. United States. Food and Drug Administration.
- Genre(s):
- Guideline Technical Report
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (12 pages)).
- NLM Unique ID:
- 101734357 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101734357